TOIIW (The Oncology Institute) Loans Receivable: $0.00 Mil (As of Mar. 2026)


TOIIW The Oncology Institute Inc TOIIW
61 GF Score
Price $0.06
! 6 Warning Signs
View Full Analysis

What is The Oncology Institute Loans Receivable?

The Oncology Institute TOIIW 61 Loans Receivable is $0.00 Mil as of Mar. 2026. GuruFocus rates TOIIW with a GF Score™ of 61/100. The stock has 6 warning signs investors should review.

The Oncology Institute's Loans Receivable for the quarter that ended in Mar. 2026 was $0.00 Mil.

The Oncology Institute Loans Receivable Related Terms

The Oncology Institute Loans Receivable Historical Data

* Premium members only.

The historical data trend for The Oncology Institute's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Oncology Institute Loans Receivable Chart

The Oncology Institute Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

The Oncology Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TOIIW
61GF Score
The Oncology Institute Inc TOIIW
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Oncology Institute Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0.00 Mil mean?
The Oncology Institute (TOIIW) has a Loans Receivable of $0.00 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on The Oncology Institute and its competitors.
Is The Oncology Institute's Loans Receivable too high?
The Oncology Institute's current Loans Receivable is $0.00 Mil. Overall, The Oncology Institute has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does The Oncology Institute's Loans Receivable compare to CYH and SRTA?
The Oncology Institute's Loans Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Healthcare Providers & Services company?
A good Loans Receivable depends on the Healthcare Providers & Services industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on The Oncology Institute and its competitors. The Oncology Institute's current Loans Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Oncology Institute stock overvalued right now?
The Oncology Institute (TOIIW) has a current Loans Receivable of $0.00 Mil. The current Loans Receivable is $0.00 Mil. The Oncology Institute's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For The Oncology Institute (TOIIW), the current Loans Receivable is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Oncology Institute Business Description

Other Exchanges TOI:USA
Address 18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
61GF Score

Get the complete analysis for TOIIW

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price